ArticleJournal of the American Society of Nephrology : JASN2025
Anti-slit Antibodies against Podocin and Kirrel1 in Pediatric and Adult Podocytopathies.
Abstract read
In one paragraph
Article in Journal of the American Society of Nephrology : JASN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 1 synthesis or guideline pooled it.
- IgM nephropathy is a controversial entity: a distinct nephropathy or part of the podocytopathy spectrum? A systematic review of the literature.BMC nephrology · 2026Pooled it
- Anti-nephrin autoantibodies in post-transplant recurrence of focal segmental glomerulosclerosis: a review.Renal failure · 2026Review
- Anti-nephrin antibodies in pediatric nephrotic syndrome: a new paradigm.Pediatric nephrology (Berlin, Germany) · 2026Review
- Anti-CD38/Anti-CD20 Rescue Therapy for Posttransplant Recurrent FSGS.Kidney international reports · 2026Article
- Antinephrin, Antipodocin, and Anti-Kirrel1 Autoantibodies in Posttransplant Recurrent FSGS.Kidney international reports · 2026Article
- Circulating Antinephrin Antibodies in Adult Chinese Patients With IgAN and Nephrotic-Range Proteinuria.Kidney international reports · 2026Article
- Antinephrin Antibodies in IgAN: Toward a Phenotype-Driven, Personalized Approach.Kidney international reports · 2026Article
- Dual anti-CD20/anti-CD38 therapy for severe recurrent FSGS with longitudinal anti-nephrin assessment.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026Article
- Recurrent Neuro-Renal Syndrome With Acute Kidney Injury From Anti-Pan-Neurofascin Antibody Resurgence: A Case Report.Kidney medicine · 2026Article
- Complement Profiling in Glomerular Disease: Insights from Laser Microdissection and Mass Spectrometry.Clinical journal of the American Society of Nephrology : CJASN · 2026Review
- Anti-nephrin autoantibodies in post-transplant recurrent focal segmental glomerulosclerosis: diagnostic advances and future directions.Clinical and experimental nephrology · 2026Review
- Autoantibodies against nephrin and podocin are associated with disease severity and steroid dependence in adult-onset nephrotic syndrome.Scientific reports · 2026Article
- Slit Diaphragm Molecular Changes in Recurrent FSGS With Antinephrin Autoantibodies.Kidney international reports · 2026Article
- How to Cure Autoimmune GN and Podocytopathies.Journal of the American Society of Nephrology : JASN · 2026Review
- Combined Anti-CD20/Anti-CD38 Therapy in Posttransplant Focal Segmental Glomerulosclerosis Recurrence: A Retrospective, International, Multicenter Study.Transplantation direct · 2026Article
- A membranous nephropathy variant mimicking minimal change disease.The journal of pathology. Clinical research · 2026Article
- Does baseline proteinuria affect the efficacy of obinutuzumab in patients with primary membranous nephropathy and minimal change disease? a single-center retrospective study.Frontiers in pharmacology · 2026Article
- Opportunities and challenges in recurrent diffuse podocytopathy post-transplantation: the critical value of the definition.Frontiers in immunology · 2026Review
- Podocytopathies.Nature reviews. Disease primers · 2025Review
- Mass Spectrometry of Minimal Change Disease and Focal Segmental Glomerulosclerosis.Kidney international reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Valentina RagliantiNephrology and Dialysis Unit, Meyer Children's Hospital IRCCS, Florence, Italy.ORCID 0000-0002-6610-3251
Maria Lucia AngelottiDepartment of Biomedical, Experimental and Clinical Sciences "Mario Serio," University of Florence, Florence, Italy.ORCID 0000-0003-3988-7852
Letizia De ChiaraDepartment of Biomedical, Experimental and Clinical Sciences "Mario Serio," University of Florence, Florence, Italy.ORCID 0000-0002-8548-2031
Marco AllinoviNephrology, Dialysis and Transplantation Unit, Careggi University Hospital AUOC, Florence, Italy.ORCID 0000-0001-9949-3543
Luigi CirilloNephrology and Dialysis Unit, Meyer Children's Hospital IRCCS, Florence, Italy.ORCID 0000-0002-0440-7356
Anna ManonellesNephrology and Transplant Department, Bellvitge University Hospital, University of Barcelona, IDIBELL, Barcelona, Spain.ORCID 0000-0003-2456-388
Josep Maria CruzadoNephrology and Transplant Department, Bellvitge University Hospital, University of Barcelona, IDIBELL, Barcelona, Spain.ORCID 0000-0003-1388-8558
Maria Elena MelicaDepartment of Biomedical, Experimental and Clinical Sciences "Mario Serio," University of Florence, Florence, Italy.ORCID 0000-0002-4599-4083
Giulia AntonelliDepartment of Biomedical, Experimental and Clinical Sciences "Mario Serio," University of Florence, Florence, Italy.ORCID 0000-0002-2555-2130
Carolina ConteDepartment of Biomedical, Experimental and Clinical Sciences "Mario Serio," University of Florence, Florence, Italy.ORCID 0000-0002-7679-2935
Anna Julie PeiredDepartment of Biomedical, Experimental and Clinical Sciences "Mario Serio," University of Florence, Florence, Italy.ORCID 0000-0001-9732-1369
Laura LasagniDepartment of Biomedical, Experimental and Clinical Sciences "Mario Serio," University of Florence, Florence, Italy.ORCID 0000-0001-6553-9160
Bärbel Lange-SperandioDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0001-8898-3459
Hans-Joachim AndersDivision of Nephrology, Medizinische Klinik and Poliklinik IV, Klinikum der LMU München, Munich, Germany.ORCID 0000-0003-2434-2956
Francesca BecherucciNephrology and Dialysis Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
Elena LazzeriDepartment of Biomedical, Experimental and Clinical Sciences "Mario Serio," University of Florence, Florence, Italy.ORCID 0000-0002-9505-2115
Benedetta MazzinghiNephrology and Dialysis Unit, Meyer Children's Hospital IRCCS, Florence, Italy.ORCID 0000-0003-2809-5622
Paola RomagnaniNephrology and Dialysis Unit, Meyer Children's Hospital IRCCS, Florence, Italy.ORCID 0000-0002-1774-8088
Funding
European Union's Horizon 2020 research and innovation program and from Tuscany Region under the ERA-Net Cofund in Personalised Medicine ERA PerMed 779282
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.